Has Paul Cagle, MD received payments from drug or device companies?

Yes. Drug and device makers reported $466,518 in general payments to Paul Cagle, MD across 509 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Paul Cagle, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Paul Cagle, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Paul Cagle, MD

Orthopaedic Surgery · New York, NYNPI 1386818474

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $345,102 of the $466,518 with a category attached, or 74.0%. 21 manufacturers reported payments, led by Arthrex at 41.2% of the total. Among orthopaedic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$466,518in general payments, 2019–2025

Across 509 payments — averaging $916.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arthrex$192K
Stryker$125K
Exactech, Inc.$75K
Medical Device Business Services, Inc.$61K
Gotham Surgical Solutions & Devices, Inc.$4K
Advita Ortho, LLC$3K
plus $7K from 15 others

$116,446in research payments, 2019–2025

Across 7 payments — averaging $16,635 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Arthrex$116K

What the payments were for

Consulting fees$345,10274%
Speaking & faculty fees$46,15010%
Travel & lodging$54,63912%
Food & beverage$17,1614%
Education$3,4661%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arthrex	219	$192,012
Stryker	132	$125,317
Exactech, Inc.	61	$74,618
Medical Device Business Services, Inc.	48	$60,752
Gotham Surgical Solutions & Devices, Inc.	6	$3,835
Advita Ortho, LLC	2	$3,104
Shoulder Innovations, Inc.	2	$1,965
Johnson & Johnson	17	$1,569
Checkpoint Surgical, Inc	2	$697
Suvon Surgical LLC	6	$626
Depuy Synthes Products, Inc.	1	$585
FX Shoulder Solutions, Inc	2	$388
Pacira Pharmaceuticals Incorporated	1	$234
Smith+Nephew	3	$152
Catalyst Orthoscience	1	$150
Paladin Technology Solutions	1	$146
Ignite Orthopedics, LLC	1	$130
Zimmer Biomet	1	$108
Lifenet Health	1	$83
Linvatec Corporation	1	$32
Avanos Medical	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

REUNION$82,352
EQUINOXE$50,649
MAKO$47,741
GLOBAL$44,246
GRYPHON$14,755
HEALIX$14,161
T2$11,101
GAMMA$10,501
AXSOS$3,200
VARIAX$3,200
AEQUALIS PERFORM$3,000
AEQUALIS ASCEND FLEX$2,200
InSet System$1,965
EQUINOXE PHX SYSTEM$1,103
TRIATHLON$1,100
ADAPT$951
Checkpoint Stimulators$650
ASNIS$561
INHANCE$456
DYNACORD$359

How this compares

$466,518 in reported general payments places this provider in the 95th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024

$203,893

Medicare patients

425

Services billed

6,176

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydroxyzine Pamoate	20	$266
Oxycodone Hcl	37	$231
Ondansetron Hcl	35	$175
Meloxicam	33	$101
Tramadol Hcl	15	$79
Cyclobenzaprine Hcl	11	$42

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in New York

Anthony RomeoNew York$26.8M
Lawrence LenkeNew York$26.8M
Edwin SuNew York$13.2M
William RicciNew York$11.6M
Steven HaasNew York$11.3M
Giles ScuderiNew York$10.7M
Joseph ZuckermanNew York$9.9M
Evan FlatowNew York$9.6M
Bradford ParsonsNew York$9.4M
Geoffrey WestrichNew York$7.1M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →